[1]
YR, P., M, B. and CK , S. 2021. GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF 25 MG FULL TABLET VERSUS 12.5 MG HALF TABLET EMPAGLIFLOZIN IN THE TREATMENT OF TYPE 2 DIABETES (T2D): A SINGLE CENTRE EXPERIENCE. Journal of the ASEAN Federation of Endocrine Societies. 36, (Jul. 2021), 44. DOI:https://doi.org/10.15605/jafes.036.S60.